Skip to main content
. 2009 Nov 3;298(1):E117–E126. doi: 10.1152/ajpendo.00318.2009

Fig. 6.

Fig. 6.

Effect of AMPK activation on NAMPT expression and mitochondrial content. A: phospho-AMPKα (Thr172)-to-AMPKα ratio in control and forskolin- and/or ionomycin-treated primary human myotubes (means ± SD, n = 4, one-way ANOVA with Dunnett's post hoc test, *P < 0.05). B: NAMPT mRNA in control and AICAR-treated primary human myotubes (means ± SD, n = 3, paired Student's t-test, *P < 0.05). C: NAMPT protein in control and AICAR-treated primary human myotubes (means ± SD, n = 4, paired Student's t-test, *P < 0.05). D: complex III protein in control and AICAR-treated primary human myotubes (means ± SD, n = 4, paired Student's t-test, *P < 0.05).